Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jul 28, 2024
Date Accepted: Jul 25, 2025

The final, peer-reviewed published version of this preprint can be found here:

Impact of a 24-Week Mobile App–Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study

Jung SY, Lee EG, Lee DE, Kim J, Han JH, Lee S, Kang HS, Lee ES, Chae H, Sim SH, Lee KS, Lee J, Lee HJ, Yoo JS, Wie GA

Impact of a 24-Week Mobile App–Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study

JMIR Mhealth Uhealth 2025;13:e64846

DOI: 10.2196/64846

PMID: 40991772

PMCID: 12459734

Impact of a 24-week mobile application-based human coaching program on body composition and lipid metabolism in breast cancer survivors with overweight or obesity: a single-arm prospective cohort study

  • So-Youn Jung; 
  • Eun-Gyeong Lee; 
  • Dong-Eun Lee; 
  • Jeongseon Kim; 
  • Jai Hong Han; 
  • Seeyoun Lee; 
  • Han-Sung Kang; 
  • Eun Sook Lee; 
  • Heejung Chae; 
  • Sung Hoon Sim; 
  • Keun Seok Lee; 
  • Jungeun Lee; 
  • Hyun Jeong Lee; 
  • Ji Sung Yoo; 
  • Gyung Ah Wie

ABSTRACT

Background:

Overweight or obesity is a prognostic factor for breast cancer recurrence and breast cancer-related deaths. However, weight control is difficult for breast cancer survivors because of menopause, chemotherapy, anti-hormonal therapy, and psychological issues.

Objective:

This study aimed to develop a 24-week mobile application-based human coaching program using Noom and evaluate its efficacy in breast cancer survivors who are overweight or obese.

Methods:

In this single-arm prospective cohort study, 130 breast cancer survivors with BMI ≥25 were enrolled and received a 24-week program including diet-, exercise-, and psychology-based contents with the trained human coach in Noom during 2019–2021. For a hyperactive group who joined more than 16 weeks, we evaluated weight, BMI, lipid level, bioimpedance, and Quality of Life at baseline, 6-month, and 12-month follow-up.

Results:

Among 130 breast cancer survivors, 101 (77.7%) and 93 (71.5%) completed the 6-month and 12-month follow-ups, respectively. In the hyperactive group (68/101, 67%), body weight and body mass index (BMI) significantly reduced (mean difference: -1.97 kg, 95% CI (confidence interval):-2.65–-1.26, P<0.001 and -0.86, 95% CI:-1.15–-0.56, P<0.001, respectively) at 6 months and maintained at 12 months without the yo-yo effect. Among the lipid panel, triglyceride (TG) levels decreased significantly (-34.13, 95% CI:-58.09- -10.17, P=0.006) and maintained at 12 months. With respect to bioimpedance components, skeletal muscle mass (SMM, kg), body fat mass (BFM, kg), percent body fat (PBF, %), waist-to-hip ratio (WHR), and visceral fat area (VFA, cm2) improved in the first 6 months. However, WHR and VFA increased during the next 6 months. Based on the EORTC QLQ C30 and BR 23, nausea or vomiting, constipation, body image, arm, and breast symptoms significantly improved during the first 6 months.

Conclusions:

This study demonstrated that a 24-week mobile application-based human coaching program is beneficial for controlling body weight, BMI, TG, and body composition in terms of bioimpedance for breast cancer survivors who are overweight or obese. Clinical Trial: ClinicalTrials.gov Identifier: NCT 05506189


 Citation

Please cite as:

Jung SY, Lee EG, Lee DE, Kim J, Han JH, Lee S, Kang HS, Lee ES, Chae H, Sim SH, Lee KS, Lee J, Lee HJ, Yoo JS, Wie GA

Impact of a 24-Week Mobile App–Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study

JMIR Mhealth Uhealth 2025;13:e64846

DOI: 10.2196/64846

PMID: 40991772

PMCID: 12459734

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.